FDA Panel Recommends Against Wider Use of Zimmer’s Dynesys Spinal System

An FDA advisory panel of medical experts has recommended against proposed wider use of Zimmer’s Dynesys spine stabilization device, according to a report by Reuters.

Advertisement

Zimmer is asking for stand-alone use of Dynesys, a series of screws and flexible spacers that aim to help align and support the spine, which is already approved for use in patients with back problems who undergo surgical fusion.

Panel members questioned how the device would hold up over time and expressed concern about possible breakage, but they added that the device holds promise.

Read Reuters’ report on Zimmer’s Dynesys spinal device.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • Since March 25, there have been two key developments in lawsuits involving spine medtech companies. 1. The U.S. Court of…

  • The highest-paid CFOs at spine and orthopedic medtech companies saw total compensation reaching in the mid-single digits and beyond. Here…

Advertisement

Comments are closed.